摘要:
Systems, methods and computer program products for tracking objects in an area of interest are described. According to an embodiment, an object is tracked as follows. First position information relating to the object is received from a first sensor and translated to a coordinate system of a map. The object is displayed on the map in accordance with the translated first position information. Second position information relating to the object is received from a second sensor, where the second sensor is based on a second positioning technology different from the first positioning technology. The second position information is translated to the coordinate system of the map, and the object is displayed on the map in accordance with the translated second position information. In an embodiment, other information relating to the object is also received from sensors.
摘要:
A thin-client system operative over a communications network provides a thin-client device with access to a dedicated application present at a server. Messages between the client device and the server conform to a control-oriented protocol that restricts the type of message permissible for transmission to only those descriptive of certain preselected events that are necessary for execution of the dedicated application on the server and excludes transmission of user actions that otherwise would be transmitted to the server from the client device according to conventional display-based protocols.
摘要:
The present invention concerns antibodies that react immunologically with anti-tumor antigen antibodies and compositions and methods related thereto. In particular, the antibodies that react immunologically with the anti-tumor antigen antibodies are employed in therapeutic, diagnostic, and prognostic embodiments related to cancer, including breast cancer, for example.
摘要:
Systems, methods and computer program products for the centralized control of radio frequency identification (RFID) readers are described herein. An input event control embodiment operates by receiving a signal from a non-RFID input device and commanding an RFID reader associated with the non-RFID input device to begin reading. According to an alternative time coordination embodiment, non-overlapping time slots are assigned to a plurality of RFID readers, and the RFID readers read only during their respective non-overlapping time slots. According to an alternative combined input event control/time coordination embodiment, non-overlapping time slots are assigned to a plurality of RFID readers. A signal from a non-RFID input device is received, and an RFID reader associated with the non-RFID input device is commanded to begin reading. However, such RFID reader only begins to read at the beginning of its next assigned time slot.
摘要:
Systems, methods and computer program products for the centralized control of radio frequency identification (RFID) readers are described herein. An input event control embodiment operates by receiving a signal from a non-RFID input device and commanding an RFID reader associated with the non-RFID input device to begin reading. According to an alternative time coordination embodiment, non-overlapping time slots are assigned to a plurality of RFID readers, and the RFID readers read only during their respective non-overlapping time slots. According to an alternative combined input event control/time coordination embodiment, non-overlapping time slots are assigned to a plurality of RFID readers. A signal from a non-RFID input device is received, and an RFID reader associated with the non-RFID input device is commanded to begin reading. However, such RFID reader only begins to read at the beginning of its next assigned time slot.
摘要:
The present invention concerns antibodies that react immunologically with anti-tumor antigen antibodies and compositions and methods related thereto. In particular, the antibodies that react immunologically with the anti-tumor antigen antibodies are employed in therapeutic, diagnostic, and prognostic embodiments related to cancer, including breast cancer, for example.